CAS 120202-66-6
:Sulfate d'hydrogène de clopidogrel
- (+)-(S)-5-[(2-Chlorophenyl)(methoxycarbonyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]-pyridin-5-ium hydrogen sulfate]
- (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoic acid sulfate (1:1)
- (S)-(+)-Clopidogrel hydrogen sulfate
- (S)-(+)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate bisulfate
- (S)-(+)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogen sulfate
- Areplex
- Clopidix
- Clopidogerl Bisulfate
- Clopidogrel Bisulfate
- Clopidogrel Bisulfate I
- Clopidogrel Bisulfate II
- Clopidogrel Bisulfate, FormI/FormII
- Clopidogrel Hydrogen Sulphate
- Clopidogrel Hydrogensulfate
- Clopidogrel Sulphate
- Clopidogrel bisulphate
- Clopidogrel bisulphate Ⅰ/Ⅱ
- Clopidogrel hemisulfate
- Clopidogrel sulfate
- Iscover
- Methyl (+)-(S)-A-(2-Chlorophenyl)-6,7-Dihydrothieno[3,2-C]Pyridine-5(4H)Acetate, Hydrogen Sulfate Salt
- Methyl (S)-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)(2-chlorophenyl)ethanoate hydrogen sulfate
- Myogrel
- Plavitor
- Plavix
- Sr 25990C
- Stroka
- Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (S)-, sulfate (1:1)
- Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (αS)-, sulfate (1:1)
- Trombex
- Zyllt
- Clopidogrel hydrogen sulfate
- (S)-alpha-(2-Chlorophenyl)-6,7-dihydrothieno[3.2-c]pyridine-5(4H)-aceticacidmethylesterhydrogensulfate
- Clopidogrelhydrogenesulfate
- Clopidogrel (Hydrogen)
- (2-Chlorophenyl)-6,7–dihydrothieno[3,2-C]pyridine-5-(4H)-acetic acid methyl ester sulfate
- d-Clopidogrel
- Voir plus de synonymes
(S)-(+)-Clopidogrel Sulfate
CAS :Formule :C16H16ClNO2S·H2SO4Degré de pureté :>98.0%(HPLC)(N)Couleur et forme :White to Almost white powder to crystalMasse moléculaire :419.89Clopidogrel hydrogen sulfate
CAS :Clopidogrel hydrogen sulfateFormule :C16H18ClNO6S2Degré de pureté :99.4%Couleur et forme :Off-WhiteMasse moléculaire :419.02641CLOPIDOGREL HYDROGEN SULFATE CRS
CAS :CLOPIDOGREL HYDROGEN SULFATE CRSFormule :C16H18ClNO6S2Couleur et forme :White. Whitish. Powder.Masse moléculaire :419.9002Clopidogrel Bisulfate
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H16ClNO2S·H2SO4Couleur et forme :White Off-White PowderMasse moléculaire :321.05903Thieno[3,2-c]pyridine-5(4H)-acetic acid,a-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (aS)-, sulfate (1:1)
CAS :Formule :C16H18ClNO6S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :419.9002Clopidogrel hydrogen sulfate
CAS :Clopidogrel hydrogen sulfate is a selective P2Y12 receptor blocker that inhibits platelet adhesion and aggregation.Formule :C16H16ClNO2S·H2SO4Degré de pureté :99.57% - 99.79%Couleur et forme :SolidMasse moléculaire :419.9Clopidogrel hydrogen sulfate
CAS :Clopidogrel hydrogen sulfateDegré de pureté :≥98%Masse moléculaire :419.9g/molClopidogrel Sulfate
CAS :Formule :C16H16ClNO2S·H2SO4Couleur et forme :White To Off-White SolidMasse moléculaire :321.82 98.07(S)-(+)-Clopidogrel hydrogen sulfate
CAS :Formule :C16H16ClNO2S·H2SO4Degré de pureté :≥ 98.0%Couleur et forme :White to off-white powderMasse moléculaire :419.90S-(+)-Clopidogrel hydrogen sulfate - Bio-X ™
CAS :Clopidogrel is a potent inhibitor of the platelet aggregation. It reduces blood clotting by inhibiting the ADP receptor on the surface of platelets, thereby inhibiting the aggregation and adhesion of platelets. Clopidogrel has been shown to be effective in preventing thrombosis, myocardial infarction (heart attack), and stroke. Clopidogrel inhibits the activity of cytochrome P450 3A4 (CYP3A4) and p2Y 12 receptors. Clopidogrel has been shown to have synergic effects with nonsteroidal anti-inflammatory drugs (NSAIDs). The polymorphic nature of Clopidogrel can be monitored using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantification in biological samples such as human serum and plasma.Formule :C16H16ClNO2S•H2SO4Degré de pureté :Min. 98 Area-%Couleur et forme :PowderMasse moléculaire :419.9 g/molS-(+)-Clopidogrel Hydrogen Sulfate
CAS :Applications Used as an antithrombotic.
References Mills, D.C.B., et al.: Arterioscler. Thromb., 12, 430 (1992), Feuerstein, G., et al.: Exp. Opin. Invest. Drugs, 4, 425 (1995)Formule :C16H16ClNO2S·H2O4SCouleur et forme :Off-WhiteMasse moléculaire :419.9S-(+)-Clopidogrel hydrogen sulfate
CAS :Clopidogrel is a potent inhibitor of the platelet aggregation. It reduces blood clotting by inhibiting the ADP receptor on the surface of platelets, thereby inhibiting the aggregation and adhesion of platelets. Clopidogrel has been shown to be effective in preventing thrombosis, myocardial infarction (heart attack), and stroke. Clopidogrel inhibits the activity of cytochrome P450 3A4 (CYP3A4) and p2Y 12 receptors. Clopidogrel has been shown to have synergic effects with nonsteroidal anti-inflammatory drugs (NSAIDs). The polymorphic nature of Clopidogrel can be monitored using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantification in biological samples such as human serum and plasma.
Formule :C16H18ClNO6S2Degré de pureté :Min. 98 Area-%Couleur et forme :White PowderMasse moléculaire :419.9 g/mol














